| 초록 |
Objectives: This baseline study sought to determine the validity of the Dialysis Symptom Index (DSI) – Waray version as a tool for identifying the symptom clusters observed and its severity among Filipino chronic kidney disease patients on maintenance hemodialysis (MHD). Methods: A cohort single-center analytical study conducted at the Hemodialysis Unit of Remedios Trinidad Romualdez Hospital in Tacloban City, Leyte, Philippines. Instruments include a Patient Information Form (PIF) and DSI – Waray version. Descriptive statistics and Pearson’s correlation coefficient were used to determine the associations between demographic, clinical and laboratory profiles, symptom clusters, and hemodialysis efficiency. Cronbach’s alpha coefficient was used to determine internal consistency and reliability of the DSI – Waray version. Results: Thirty-four (34) patients were included as primary respondents during the specified period of data gathering on May, July, and October 2022. Mean age was 57.15 years, majority were male (61.76%), diabetics (55.88%), and had efficient hemodialysis with an average Kt/V of ≥1.2 (79.41%). Patients have high symptom burden with all 34 patients presenting with symptoms across all three visits (mean= 7; SD = 5.9). Significant associations between the clinical and demographic profile and the uremic, gastrointestinal, skin, emotional, and neuromuscular symptom clusters were found. Significant association was observed between the serum albumin and gastrointestinal symptom cluster; and serum creatinine and sexual symptom cluster. Significant association between hemodialysis efficiency and the uremic, skin, and sexual symptom clusters were noted. DSI-Waray version showed good test-retest reliability with good internal consistency. Guttman split-half correlation was >0.80 indicating that all parts of the test contributed equally to what is being measured, specifically the severity of symptoms experienced. Conclusions: CKD patients on MHD reported high symptom burden. DSI – Waray Version is a valid tool that may be used to assess symptoms that may be experienced by these patients. |